Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
23.05. | Pfizer Inks $1.25 Billion Deal with 3SBio for Global Rights to Cancer Drug | ||
22.05. | Lonza Launches Design2Optimize for Faster Small Molecule API Development | ||
22.05. | Sanofi to Acquire Vigil Neuroscience for $470M | ||
22.05. | Celltrion's YUFLYMA Granted Expanded Interchangeable Designation | ||
22.05. | The BioMed X Institute, Boehringer Ingelheim Launch Call for Research Proposals | ||
22.05. | Bora Biologics to Expand San Diego Manufacturing Facility | ||
22.05. | Shilpa Biologicals Opens Manufacturing Site for Fully Integrated ADC Development | ||
21.05. | Northway Biotech Enters Manufacturing Agreement with Kaida BioPharma | ||
21.05. | IDT Biologika Enters CMDO Partnership to Accelerate Global Growth | ||
21.05. | Antengene & MSD Enter into a Global Clinical Collaboration | ||
21.05. | Waters Acquires Halo Labs, Expands Biologic Analysis Portfolio | ||
20.05. | Regeneron in Deal to Acquire 23andMe for $256M | ||
20.05. | NextCell, Fujifilm Irvine Scientific Enter Strategic Pact | ||
20.05. | CellProthera Selects CELLforCURE by SEQENS for Phase 3 GMP Manufacturing | ||
20.05. | CS Analytical Laboratory Opens Package Distribution Testing Service Expansion | ||
20.05. | Shift Bioscience Announces Board and Advisor Appointments | ||
19.05. | Zealand Pharma Appoints Chief Development Officer | ||
19.05. | GC Biopharma Partners with Körber to Implement MES | ||
19.05. | Cellino's iPSC Manufacturing Technology Receives FDA AMT Designation | ||
19.05. | FDA Approves Novavax COVID-19 Vaccine for High-Risk Adults | ||
16.05. | Rznomics & Eli Lilly Enter Global Licensing Agreement | ||
16.05. | BioMarin to Acquire Inozyme Pharma for $270M | ||
16.05. | Novo Nordisk CEO to Step Down | ||
15.05. | groninger Invests $14M in New Charlotte, NC Headquarters | ||
15.05. | Abzena Establishes Scientific Advisory Board to Support Innovation Strategy |